The STem Cell Application Researches and Trials In NeuroloGy-2 (STARTING-2) Study "STARTING-2"


Phase 3 Results N/A

Summary of Purpose

The objectives of this study was to test hypothesis that ischemic stroke patients having moderate to severe persistent neurologic deficit will have better outcomes with intravenous transplantation of autologous mesenchymal stem cells (MSCs) expanded with autologous serum that is obtained at acute phase of stroke than patients receiving standard treatment.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 April 2017.

1 Nov 2012 25 Oct 2012 1 Dec 2017 1 Dec 2017 1 Apr 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment